| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.921 | 0.003 | 0.921 | Aldehyde oxidase inhibitor | 0.536 0.028 DBMET02739 0.614 0.017 DBMET02740 0.578 0.022 DBMET02741 | ||
| 0.609 | 0.035 | 0.609 | Caspase 9 stimulant | 0.324 0.169 DBMET02739 0.359 0.139 DBMET02740 0.407 0.107 DBMET02741 | ||
| 0.503 | 0.002 | 0.519 | Histamine N-methyltransferase inhibitor | 0.416 0.002 DBMET02739 0.272 0.004 DBMET02740 0.519 0.002 DBMET02741 | DBMET02741 | |
| 0.486 | 0.025 | 0.486 | Spasmolytic | 0.197 0.123 DBMET02739 0.267 0.084 DBMET02740 | ||
| 0.416 | 0.067 | 0.416 | Histamine release inhibitor | 0.213 0.187 DBMET02739 0.267 0.143 DBMET02740 0.382 0.085 DBMET02741 | ||
| 0.337 | 0.011 | 0.337 | Nav1.2 sodium channel blocker | 0.191 0.038 DBMET02739 0.208 0.032 DBMET02740 0.261 0.02 DBMET02741 | ||
| 0.337 | 0.034 | 0.337 | Psychostimulant | 0.303 0.042 DBMET02739 0.246 0.06 DBMET02740 0.277 0.049 DBMET02741 | ||
| 0.32 | 0.048 | 0.32 | Cardiotonic | 0.169 0.153 DBMET02739 | ||
| 0.327 | 0.068 | 0.327 | Vasodilator, coronary | 0.238 0.147 DBMET02739 0.27 0.115 DBMET02740 | ||
| 0.266 | 0.01 | 0.266 | ATPase inhibitor | 0.204 0.034 DBMET02739 0.209 0.031 DBMET02740 0.175 0.065 DBMET02741 | ||
| 0.264 | 0.012 | 0.264 | Nav1.3 sodium channel blocker | 0.206 0.022 DBMET02739 0.176 0.034 DBMET02740 0.124 0.07 DBMET02741 | ||
| 0.284 | 0.045 | 0.361 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.261 0.055 DBMET02739 0.205 0.087 DBMET02740 0.361 0.022 DBMET02741 | DBMET02741 | |
| 0.298 | 0.066 | 0.311 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.27 0.088 DBMET02739 0.307 0.059 DBMET02740 0.311 0.056 DBMET02741 | DBMET02741 | |
| 0.237 | 0.011 | 0.237 | Nav1.6 sodium channel blocker | 0.171 0.034 DBMET02739 0.175 0.031 DBMET02740 0.192 0.022 DBMET02741 | ||
| 0.225 | 0.003 | 0.549 | Botulinum neurotoxin type A inhibitor | 0.44 0.002 DBMET02739 0.358 0.002 DBMET02740 0.549 0.002 DBMET02741 | DBMET02741 | |
| 0.255 | 0.048 | 0.255 | Sigma receptor agonist | |||
| 0.334 | 0.13 | 0.334 | 5 Hydroxytryptamine release inhibitor | 0.248 0.23 DBMET02739 0.265 0.208 DBMET02740 0.327 0.137 DBMET02741 | ||
| 0.258 | 0.055 | 0.258 | Amyloid beta aggregation inhibitor | 0.25 0.058 DBMET02739 0.21 0.073 DBMET02740 0.23 0.064 DBMET02741 | ||
| 0.26 | 0.067 | 0.269 | Antiamyloidogenic | 0.269 0.063 DBMET02739 0.237 0.077 DBMET02740 0.25 0.071 DBMET02741 | DBMET02739 | |
| 0.201 | 0.01 | 0.201 | NADH dehydrogenase inhibitor | 0.107 0.037 DBMET02739 0.113 0.032 DBMET02740 0.118 0.03 DBMET02741 | ||
| 0.237 | 0.056 | 0.237 | DNA methylase inhibitor | 0.155 0.113 DBMET02739 0.144 0.123 DBMET02740 0.15 0.117 DBMET02741 | ||
| 0.236 | 0.062 | 0.289 | Peptidyltransferase inhibitor | 0.251 0.05 DBMET02739 0.289 0.029 DBMET02740 0.266 0.04 DBMET02741 | DBMET02740 | |
| 0.247 | 0.076 | 0.319 | Superoxide dismutase inhibitor | 0.253 0.073 DBMET02739 0.254 0.072 DBMET02740 0.319 0.044 DBMET02741 | DBMET02741 | |
| 0.187 | 0.027 | 0.187 | Chelator | 0.139 0.04 DBMET02739 0.133 0.044 DBMET02740 0.108 0.067 DBMET02741 | ||
| 0.27 | 0.113 | 0.27 | Vasodilator, peripheral | 0.234 0.14 DBMET02740 | ||
| 0.215 | 0.062 | 0.215 | DNA methyltransferase I inhibitor | |||
| 0.178 | 0.033 | 0.178 | DNA intercalator | 0.133 0.051 DBMET02739 0.15 0.043 DBMET02740 0.127 0.054 DBMET02741 | ||
| 0.141 | 0.005 | 0.141 | Potassium channel (ATP-sensitive) blocker | 0.099 0.016 DBMET02739 0.087 0.022 DBMET02740 0.081 0.027 DBMET02741 | ||
| 0.207 | 0.072 | 0.335 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.181 0.087 DBMET02739 0.174 0.092 DBMET02740 0.335 0.032 DBMET02741 | DBMET02741 | |
| 0.232 | 0.104 | 0.256 | Immunostimulant | 0.256 0.094 DBMET02740 0.214 0.112 DBMET02741 | DBMET02740 | |
| 0.174 | 0.055 | 0.174 | Acetylcholine M1 receptor antagonist | 0.133 0.092 DBMET02739 0.128 0.098 DBMET02740 0.135 0.09 DBMET02741 | ||
| 0.15 | 0.033 | 0.15 | Nav1.1 sodium channel blocker | |||
| 0.2 | 0.084 | 0.34 | Interleukin antagonist | 0.177 0.099 DBMET02739 0.246 0.063 DBMET02740 0.34 0.04 DBMET02741 | DBMET02741 | |
| 0.182 | 0.072 | 0.226 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.122 0.114 DBMET02739 0.167 0.079 DBMET02740 0.226 0.053 DBMET02741 | DBMET02741 | |
| 0.167 | 0.057 | 0.268 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.139 0.072 DBMET02739 0.131 0.076 DBMET02740 0.268 0.026 DBMET02741 | DBMET02741 | |
| 0.143 | 0.037 | 0.148 | Butyrylcholinesterase inhibitor | 0.148 0.035 DBMET02739 0.085 0.075 DBMET02740 0.086 0.075 DBMET02741 | DBMET02739 | |
| 0.139 | 0.042 | 0.15 | Interleukin 8 antagonist | 0.107 0.082 DBMET02739 0.148 0.035 DBMET02740 0.15 0.034 DBMET02741 | DBMET02741 | |
| 0.194 | 0.097 | 0.194 | Potassium channel blocker | 0.158 0.128 DBMET02739 | ||
| 0.147 | 0.05 | 0.147 | Anesthetic local | |||
| 0.181 | 0.086 | 0.181 | Anesthetic general | |||
| 0.097 | 0.005 | 0.097 | CC chemokine 4 receptor antagonist | 0.078 0.008 DBMET02739 0.062 0.015 DBMET02740 0.062 0.014 DBMET02741 | ||
| 0.18 | 0.093 | 0.242 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.139 0.131 DBMET02739 0.187 0.087 DBMET02740 0.242 0.049 DBMET02741 | DBMET02741 | |
| 0.111 | 0.029 | 0.111 | Telomerase inhibitor | 0.103 0.032 DBMET02739 0.072 0.051 DBMET02740 0.092 0.038 DBMET02741 | ||
| 0.136 | 0.055 | 0.149 | Alkylator | 0.149 0.047 DBMET02740 | DBMET02740 | |
| 0.199 | 0.121 | 0.234 | Neuropeptide Y2 antagonist | 0.213 0.098 DBMET02739 0.176 0.169 DBMET02740 0.234 0.072 DBMET02741 | DBMET02741 | |
| 0.137 | 0.064 | 0.137 | Acetylcholinesterase inhibitor | 0.121 0.077 DBMET02739 | ||
| 0.155 | 0.082 | 0.155 | Interleukin 6 antagonist | 0.139 0.107 DBMET02740 | ||
| 0.182 | 0.112 | 0.182 | ErbB-1 antagonist | |||
| 0.174 | 0.104 | 0.18 | Anticonvulsant | 0.145 0.136 DBMET02739 0.18 0.099 DBMET02741 | DBMET02741 | |
| 0.11 | 0.045 | 0.11 | Electrolyte absorption antagonist | 0.088 0.079 DBMET02741 | ||
| 0.102 | 0.04 | 0.102 | Interleukin 5 antagonist | 0.097 0.045 DBMET02740 | ||
| 0.12 | 0.058 | 0.187 | Alpha 2b adrenoreceptor antagonist | 0.187 0.027 DBMET02739 0.096 0.079 DBMET02740 0.121 0.057 DBMET02741 | DBMET02739 | |
| 0.135 | 0.073 | 0.135 | Aurora-C kinase inhibitor | 0.12 0.106 DBMET02739 0.126 0.091 DBMET02740 | ||
| 0.148 | 0.092 | 0.236 | Protein kinase (CK1) gamma 3 inhibitor | 0.145 0.096 DBMET02739 0.125 0.12 DBMET02740 0.236 0.031 DBMET02741 | DBMET02741 | |
| 0.08 | 0.025 | 0.118 | NMDA 2C receptor antagonist | 0.056 0.051 DBMET02739 0.064 0.04 DBMET02740 0.118 0.011 DBMET02741 | DBMET02741 | |
| 0.064 | 0.01 | 0.064 | Plasmepsin II inhibitor | 0.049 0.019 DBMET02739 0.045 0.022 DBMET02740 0.056 0.014 DBMET02741 | ||
| 0.075 | 0.022 | 0.079 | Potassium channel (Ca-activated) blocker | 0.076 0.021 DBMET02739 0.079 0.019 DBMET02741 | DBMET02741 | |
| 0.153 | 0.1 | 0.153 | Lipocortins synthesis antagonist | |||
| 0.122 | 0.072 | 0.211 | Glutamate receptor antagonist | 0.175 0.035 DBMET02739 0.15 0.051 DBMET02740 0.211 0.023 DBMET02741 | DBMET02741 | |
| 0.13 | 0.08 | 0.133 | Cytokine production inhibitor | 0.118 0.091 DBMET02739 0.133 0.076 DBMET02741 | DBMET02741 | |
| 0.089 | 0.039 | 0.089 | Interferon agonist | |||
| 0.073 | 0.026 | 0.075 | Heat shock protein 90 beta antagonist | 0.075 0.024 DBMET02739 0.056 0.047 DBMET02741 | DBMET02739 | |
| 0.101 | 0.054 | 0.101 | Potassium channel (Ca-activated) activator | 0.084 0.071 DBMET02740 0.088 0.067 DBMET02741 | ||
| 0.058 | 0.012 | 0.058 | Factor XIIIa inhibitor | |||
| 0.072 | 0.026 | 0.143 | Corticotropin releasing factor 2 receptor antagonist | 0.107 0.005 DBMET02739 0.068 0.031 DBMET02740 0.143 0.004 DBMET02741 | DBMET02741 | |
| 0.095 | 0.05 | 0.173 | NMDA receptor antagonist | 0.127 0.032 DBMET02739 0.12 0.035 DBMET02740 0.173 0.019 DBMET02741 | DBMET02741 | |
| 0.204 | 0.16 | 0.225 | Immunomodulator | 0.209 0.154 DBMET02740 0.225 0.137 DBMET02741 | DBMET02741 | |
| 0.115 | 0.072 | 0.115 | Acetylcholine muscarinic antagonist | |||
| 0.182 | 0.139 | 0.659 | 5 Hydroxytryptamine release stimulant | 0.659 0.01 DBMET02739 0.394 0.047 DBMET02740 0.532 0.023 DBMET02741 | DBMET02739 | |
| 0.063 | 0.021 | 0.063 | Potassium channel (Inward rectifier) blocker | |||
| 0.219 | 0.177 | 0.241 | Immunosuppressant | 0.241 0.155 DBMET02740 | DBMET02740 | |
| 0.148 | 0.111 | 0.218 | Death-associated protein kinase 2 inhibitor | 0.149 0.109 DBMET02739 0.218 0.024 DBMET02741 | DBMET02741 | |
| 0.088 | 0.052 | 0.096 | Myeloperoxidase inhibitor | 0.092 0.046 DBMET02739 0.093 0.044 DBMET02740 0.096 0.04 DBMET02741 | DBMET02741 | |
| 0.201 | 0.167 | 0.201 | Caspase 3 stimulant | |||
| 0.173 | 0.141 | 0.226 | DNA damaging | 0.186 0.128 DBMET02739 0.195 0.12 DBMET02740 0.226 0.096 DBMET02741 | DBMET02741 | |
| 0.109 | 0.078 | 0.109 | Topoisomerase II inhibitor | 0.102 0.084 DBMET02739 0.098 0.088 DBMET02740 | ||
| 0.096 | 0.065 | 0.096 | Sphingomyelinase inhibitor | |||
| 0.063 | 0.032 | 0.063 | Bcl-xL inhibitor | 0.061 0.037 DBMET02739 0.06 0.039 DBMET02741 | ||
| 0.074 | 0.044 | 0.078 | Phospholipase D inhibitor | 0.078 0.037 DBMET02740 | DBMET02740 | |
| 0.039 | 0.009 | 0.039 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.099 | 0.07 | 0.122 | Factor V inhibitor | 0.119 0.039 DBMET02739 0.115 0.044 DBMET02740 0.122 0.037 DBMET02741 | DBMET02741 | |
| 0.143 | 0.114 | 0.145 | Cyclin-dependent kinase 3 inhibitor | 0.145 0.108 DBMET02739 0.14 0.123 DBMET02740 | DBMET02739 | |
| 0.106 | 0.077 | 0.131 | CDK3/cyclin E inhibitor | 0.131 0.042 DBMET02739 0.112 0.067 DBMET02740 0.121 0.055 DBMET02741 | DBMET02739 | |
| 0.11 | 0.083 | 0.11 | Cholinergic antagonist | |||
| 0.164 | 0.138 | 0.164 | Vasodilator | |||
| 0.089 | 0.064 | 0.137 | Falcipain inhibitor | 0.136 0.037 DBMET02739 0.103 0.053 DBMET02740 0.137 0.037 DBMET02741 | DBMET02741 | |
| 0.125 | 0.101 | 0.125 | Cholinergic | |||
| 0.154 | 0.132 | 0.157 | Growth factor agonist | 0.157 0.127 DBMET02740 | DBMET02740 | |
| 0.159 | 0.137 | 0.159 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.085 | 0.064 | 0.132 | Falcipain 2 inhibitor | 0.129 0.038 DBMET02739 0.098 0.054 DBMET02740 0.132 0.037 DBMET02741 | DBMET02741 | |
| 0.083 | 0.064 | 0.083 | Hematopoietic | 0.081 0.071 DBMET02740 0.083 0.064 DBMET02741 | ||
| 0.039 | 0.02 | 0.041 | Phosphoglycerate kinase inhibitor | 0.041 0.019 DBMET02741 | DBMET02741 | |
| 0.105 | 0.086 | 0.105 | Acetylcholine antagonist | |||
| 0.047 | 0.029 | 0.047 | Neuraminidase (Influenza A) inhibitor | |||
| 0.128 | 0.112 | 0.129 | MAP kinase 3 inhibitor | 0.129 0.11 DBMET02741 | DBMET02741 | |
| 0.042 | 0.027 | 0.047 | Cathepsin F inhibitor | 0.047 0.016 DBMET02739 0.042 0.028 DBMET02740 0.046 0.018 DBMET02741 | DBMET02739 | |
| 0.045 | 0.031 | 0.071 | Potassium channel small-conductance Ca-activated blocker | 0.056 0.02 DBMET02739 0.071 0.012 DBMET02741 | DBMET02741 | |
| 0.201 | 0.188 | 0.316 | Interleukin 2 agonist | 0.197 0.194 DBMET02739 0.247 0.122 DBMET02740 0.316 0.063 DBMET02741 | DBMET02741 | |
| 0.123 | 0.111 | 0.166 | Thiol protease inhibitor | 0.131 0.095 DBMET02739 0.142 0.077 DBMET02740 0.166 0.057 DBMET02741 | DBMET02741 | |
| 0.09 | 0.078 | 0.09 | Gastric antisecretory | |||
| 0.075 | 0.064 | 0.162 | Adrenaline agonist | 0.109 0.031 DBMET02739 0.162 0.012 DBMET02740 | DBMET02740 | |
| 0.034 | 0.024 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.086 | 0.078 | 0.105 | Interleukin 1 beta converting enzyme inhibitor | 0.105 0.052 DBMET02739 0.095 0.065 DBMET02740 0.091 0.071 DBMET02741 | DBMET02739 | |
| 0.047 | 0.039 | 0.047 | Topoisomerase II beta inhibitor | |||
| 0.056 | 0.049 | 0.056 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.02 | 0.014 | 0.024 | Toll-Like receptor 8 agonist | 0.019 0.017 DBMET02740 0.024 0.007 DBMET02741 | DBMET02741 | |
| 0.045 | 0.039 | 0.049 | Benzodiazepine antagonist | 0.049 0.028 DBMET02739 | DBMET02739 | |
| 0.112 | 0.109 | 0.117 | Peroxidase inhibitor | 0.117 0.103 DBMET02741 | DBMET02741 | |
| 0.064 | 0.062 | 0.066 | Aminopeptidase I inhibitor | 0.066 0.059 DBMET02740 | DBMET02740 | |
| 0.059 | 0.058 | 0.066 | Beta 3 adrenoreceptor antagonist | 0.066 0.041 DBMET02740 | DBMET02740 | |
| 0.09 | 0.089 | 0.122 | Folate antagonist | 0.108 0.052 DBMET02739 0.122 0.037 DBMET02740 0.12 0.039 DBMET02741 | DBMET02740 | |
| 0.108 | 0.107 | 0.12 | Toll-Like receptor antagonist | 0.12 0.084 DBMET02741 | DBMET02741 | |
| 0.233 | 0.234 | 0.239 | Apoptosis agonist | 0.239 0.226 DBMET02740 | DBMET02740 | |
| 0.016 | 0.019 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.012 DBMET02739 0.017 0.016 DBMET02740 0.017 0.015 DBMET02741 | DBMET02739 | |
| 0.096 | 0.099 | 0.104 | Cell adhesion inhibitor | 0.101 0.087 DBMET02739 0.104 0.082 DBMET02740 0.097 0.095 DBMET02741 | DBMET02740 | |
| 0.08 | 0.087 | 0.157 | Protein kinase C zeta inhibitor | 0.106 0.043 DBMET02739 0.102 0.048 DBMET02740 0.157 0.018 DBMET02741 | DBMET02741 | |
| 0.077 | 0.085 | 0.139 | Aminopeptidase B inhibitor | 0.087 0.075 DBMET02740 0.139 0.043 DBMET02741 | DBMET02741 | |
| 0.182 | 0.191 | 0.332 | 5 Hydroxytryptamine uptake stimulant | 0.332 0.031 DBMET02739 0.188 0.176 DBMET02740 0.325 0.034 DBMET02741 | DBMET02739 | |
| 0.08 | 0.09 | 0.089 | MAP kinase kinase 1 inhibitor | 0.089 0.072 DBMET02740 | DBMET02740 | |
| 0.122 | 0.133 | 0.198 | LIM domain kinase 1 inhibitor | 0.131 0.119 DBMET02739 0.129 0.122 DBMET02740 0.198 0.064 DBMET02741 | DBMET02741 | |
| 0.052 | 0.063 | 0.085 | NMDA receptor agonist | 0.066 0.039 DBMET02739 0.079 0.03 DBMET02740 0.085 0.026 DBMET02741 | DBMET02741 | |
| 0.056 | 0.07 | 0.067 | Beta 2 adrenoreceptor agonist | 0.06 0.05 DBMET02739 0.067 0.025 DBMET02740 | DBMET02740 | |
| 0.043 | 0.06 | 0.069 | Cannabinoid CB1 receptor agonist | 0.069 0.036 DBMET02740 | DBMET02740 | |
| 0.024 | 0.049 | 0.052 | Complement C3a chemotactic receptor antagonist | 0.042 0.031 DBMET02739 0.042 0.031 DBMET02740 0.052 0.025 DBMET02741 | DBMET02741 | |
| 0.056 | 0.081 | 0.09 | Topoisomerase II alpha inhibitor | 0.09 0.046 DBMET02740 | DBMET02740 | |
| 0.104 | 0.129 | 0.191 | Thrombolytic | 0.128 0.101 DBMET02739 0.135 0.094 DBMET02740 0.191 0.056 DBMET02741 | DBMET02741 | |
| 0.042 | 0.068 | 0.075 | Glucagon-like peptide 1 agonist | 0.064 0.045 DBMET02740 0.075 0.038 DBMET02741 | DBMET02741 | |
| 0.113 | 0.142 | 0.19 | Neuropeptide Y1 antagonist | 0.19 0.023 DBMET02739 0.172 0.037 DBMET02740 0.173 0.036 DBMET02741 | DBMET02739 | |
| 0.173 | 0.204 | 0.226 | Insulysin inhibitor | 0.189 0.175 DBMET02739 0.226 0.121 DBMET02741 | DBMET02741 | |
| 0.039 | 0.075 | 0.109 | CXC chemokine 4 receptor antagonist | 0.059 0.043 DBMET02739 0.109 0.023 DBMET02741 | DBMET02741 | |
| 0.106 | 0.143 | 0.138 | Heat shock protein 90 antagonist | 0.138 0.087 DBMET02739 | DBMET02739 | |
| 0.094 | 0.132 | 0.187 | Histone deacetylase SIRT1 inhibitor | 0.169 0.047 DBMET02739 0.154 0.058 DBMET02740 0.187 0.036 DBMET02741 | DBMET02741 | |
| 0.027 | 0.067 | 0.042 | NMDA receptor subunit 3B antagonist | 0.042 0.032 DBMET02741 | DBMET02741 | |
| 0.036 | 0.078 | 0.073 | Myc inhibitor | 0.063 0.026 DBMET02739 0.073 0.017 DBMET02740 | DBMET02740 | |
| 0.027 | 0.07 | 0.039 | Neurokinin 2 agonist | 0.039 0.033 DBMET02741 | DBMET02741 | |
| 0.049 | 0.093 | 0.076 | CXC chemokine receptor antagonist | 0.076 0.041 DBMET02741 | DBMET02741 | |
| 0.072 | 0.116 | 0.097 | Protein kinase (CK2) alpha inhibitor | 0.097 0.079 DBMET02741 | DBMET02741 | |
| 0.034 | 0.078 | 0.12 | Glutamate (mGluR1) antagonist | 0.116 0.012 DBMET02739 0.09 0.019 DBMET02740 0.12 0.011 DBMET02741 | DBMET02741 | |
| 0.037 | 0.082 | 0.05 | Beta adrenoreceptor agonist | 0.05 0.018 DBMET02740 | DBMET02740 | |
| 0.033 | 0.08 | 0.054 | Toll-Like receptor 8 antagonist | 0.054 0.037 DBMET02741 | DBMET02741 | |
| 0.061 | 0.11 | 0.088 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.088 0.052 DBMET02741 | DBMET02741 | |
| 0.039 | 0.093 | 0.132 | NMDA 2 receptor antagonist | 0.081 0.043 DBMET02739 0.081 0.043 DBMET02740 0.132 0.021 DBMET02741 | DBMET02741 | |
| 0.07 | 0.124 | 0.116 | Nitric-oxide synthase inhibitor | 0.1 0.06 DBMET02739 0.093 0.071 DBMET02740 0.116 0.04 DBMET02741 | DBMET02741 | |
| 0.024 | 0.081 | 0.046 | AMPA receptor antagonist | 0.046 0.035 DBMET02741 | DBMET02741 | |
| 0.139 | 0.196 | 0.243 | Calpain inhibitor | 0.243 0.071 DBMET02739 0.171 0.147 DBMET02740 0.17 0.148 DBMET02741 | DBMET02739 | |
| 0.011 | 0.069 | 0.039 | AMPA 3 receptor antagonist | 0.035 0.017 DBMET02739 0.039 0.014 DBMET02741 | DBMET02741 | |
| 0.026 | 0.086 | 0.06 | Neuropeptide agonist | 0.06 0.038 DBMET02741 | DBMET02741 | |
| 0.098 | 0.159 | 0.146 | CDC-like kinase 4 inhibitor | 0.146 0.104 DBMET02741 | DBMET02741 | |
| 0.064 | 0.128 | 0.103 | Alpha 2c adrenoreceptor antagonist | 0.103 0.063 DBMET02739 | DBMET02739 | |
| 0.092 | 0.157 | 0.126 | Diuretic | 0.126 0.098 DBMET02741 | DBMET02741 | |
| 0.032 | 0.097 | 0.067 | Potassium channel (ATP-sensitive) activator | 0.067 0.011 DBMET02739 0.051 0.029 DBMET02740 0.054 0.023 DBMET02741 | DBMET02739 | |
| 0.061 | 0.127 | 0.096 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.065 DBMET02740 0.096 0.049 DBMET02741 | DBMET02741 | |
| 0.055 | 0.122 | 0.083 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.083 0.066 DBMET02741 | DBMET02741 | |
| 0.033 | 0.1 | 0.07 | Potassium channel (Inward rectifier) activator | 0.07 0.012 DBMET02739 0.053 0.03 DBMET02740 0.057 0.024 DBMET02741 | DBMET02739 | |
| 0.033 | 0.102 | 0.049 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET02739 0.049 0.035 DBMET02740 | DBMET02740 | |
| 0.099 | 0.169 | 0.129 | Polo-like kinase-3 inhibitor | 0.129 0.111 DBMET02741 | DBMET02741 | |
| 0.064 | 0.136 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | 0.114 0.037 DBMET02741 | DBMET02741 | |
| 0.078 | 0.151 | 0.182 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.182 0.058 DBMET02741 | DBMET02741 | |
| 0.121 | 0.195 | 0.218 | Neurotensin receptor agonist | 0.191 0.04 DBMET02739 0.182 0.048 DBMET02740 0.218 0.028 DBMET02741 | DBMET02741 | |
| 0.056 | 0.132 | 0.077 | Histamine H2 receptor antagonist | 0.077 0.071 DBMET02739 | DBMET02739 | |
| 0.079 | 0.158 | 0.147 | Protein kinase (CK1) gamma inhibitor | 0.147 0.069 DBMET02741 | DBMET02741 | |
| 0.171 | 0.25 | 0.379 | GABA C receptor rho-3 antagonist | 0.338 0.092 DBMET02739 0.235 0.168 DBMET02740 0.379 0.071 DBMET02741 | DBMET02741 | |
| 0.032 | 0.112 | 0.049 | Parathyroid hormone antagonist | 0.049 0.024 DBMET02741 | DBMET02741 | |
| 0.023 | 0.104 | 0.036 | AMPA 4 receptor antagonist | 0.036 0.034 DBMET02741 | DBMET02741 | |
| 0.111 | 0.193 | 0.204 | Death-associated protein kinase 3 inhibitor | 0.147 0.127 DBMET02739 0.204 0.073 DBMET02741 | DBMET02741 | |
| 0.005 | 0.087 | 0.026 | AMPA 1 receptor antagonist | 0.026 0.023 DBMET02741 | DBMET02741 | |
| 0.006 | 0.088 | 0.014 | Somatostatin 2 agonist | 0.014 0.011 DBMET02741 | DBMET02741 | |
| 0.081 | 0.164 | 0.126 | Protein kinase C nu inhibitor | 0.126 0.087 DBMET02741 | DBMET02741 | |
| 0.064 | 0.152 | 0.091 | Transforming growth factor beta 3 antagonist | 0.091 0.036 DBMET02741 | DBMET02741 | |
| 0.012 | 0.101 | 0.031 | Gonadotropin-releasing hormone receptor antagonist | 0.031 0.027 DBMET02739 | DBMET02739 | |
| 0.017 | 0.107 | 0.067 | NMDA 2A receptor antagonist | 0.052 0.036 DBMET02739 0.067 0.026 DBMET02741 | DBMET02741 | |
| 0.083 | 0.177 | 0.169 | Anticoagulant | 0.121 0.111 DBMET02740 0.169 0.066 DBMET02741 | DBMET02741 | |
| 0.038 | 0.132 | 0.074 | Sirtuin 1 inhibitor | 0.065 0.051 DBMET02739 0.074 0.041 DBMET02741 | DBMET02741 | |
| 0.052 | 0.148 | 0.092 | Potassium channel activator | 0.092 0.057 DBMET02739 0.085 0.068 DBMET02740 | DBMET02739 | |
| 0.009 | 0.107 | 0.035 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.022 DBMET02739 0.035 0.017 DBMET02741 | DBMET02741 | |
| 0.023 | 0.122 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.014 DBMET02739 0.044 0.018 DBMET02741 | DBMET02739 | |
| 0.093 | 0.195 | 0.13 | Hemostatic | 0.13 0.096 DBMET02741 | DBMET02741 | |
| 0.09 | 0.195 | 0.246 | Growth hormone agonist | 0.122 0.118 DBMET02740 0.246 0.044 DBMET02741 | DBMET02741 | |
| 0.088 | 0.194 | 0.124 | Cyclin-dependent kinase 8 inhibitor | 0.124 0.112 DBMET02741 | DBMET02741 | |
| 0.061 | 0.166 | 0.153 | Histone deacetylase class III inhibitor | 0.134 0.058 DBMET02739 0.11 0.079 DBMET02740 0.153 0.041 DBMET02741 | DBMET02741 | |
| 0.077 | 0.184 | 0.135 | Protein kinase (CK1) gamma 1 inhibitor | 0.135 0.082 DBMET02741 | DBMET02741 | |
| 0.018 | 0.125 | 0.043 | Growth hormone release inhibitor | 0.043 0.028 DBMET02741 | DBMET02741 | |
| 0.09 | 0.198 | 0.18 | Heat shock protein 90 alpha antagonist | 0.18 0.062 DBMET02739 0.159 0.078 DBMET02741 | DBMET02739 | |
| 0.007 | 0.116 | 0.031 | Somatostatin 2 antagonist | 0.031 0.02 DBMET02741 | DBMET02741 | |
| 0.016 | 0.126 | 0.048 | Somatostatin 5 agonist | 0.048 0.013 DBMET02741 | DBMET02741 | |
| 0.063 | 0.175 | 0.124 | Nav1.4 sodium channel blocker | 0.124 0.048 DBMET02741 | DBMET02741 | |
| 0.012 | 0.129 | 0.038 | Somatostatin agonist | 0.038 0.018 DBMET02741 | DBMET02741 | |
| 0.061 | 0.181 | 0.103 | Protein kinase (CK1) gamma 2 inhibitor | 0.103 0.081 DBMET02741 | DBMET02741 | |
| 0.021 | 0.146 | 0.056 | Protein kinase C epsilon inhibitor | 0.056 0.034 DBMET02741 | DBMET02741 | |
| 0.076 | 0.205 | 0.136 | Clk dual-specificity kinase inhibitor | 0.136 0.127 DBMET02741 | DBMET02741 | |
| 0.039 | 0.168 | 0.112 | Somatostatin 1 agonist | 0.112 0.027 DBMET02741 | DBMET02741 | |
| 0.056 | 0.186 | 0.12 | MAP kinase 12 inhibitor | 0.12 0.07 DBMET02741 | DBMET02741 | |
| 0.019 | 0.152 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.026 DBMET02741 | DBMET02741 | |
| 0.013 | 0.15 | 0.046 | Somatostatin 1 antagonist | 0.046 0.022 DBMET02741 | DBMET02741 | |
| 0.037 | 0.174 | 0.142 | Protein kinase B gamma inhibitor | 0.142 0.018 DBMET02741 | DBMET02741 | |
| 0.02 | 0.165 | 0.066 | Histamine H1 receptor agonist | 0.066 0.005 DBMET02739 0.057 0.01 DBMET02741 | DBMET02739 | |
| 0.021 | 0.167 | 0.05 | Beta 1 adrenoreceptor antagonist | 0.05 0.046 DBMET02740 | DBMET02740 | |
| 0.032 | 0.183 | 0.067 | Thrombin inhibitor | 0.067 0.059 DBMET02741 | DBMET02741 | |
| 0.12 | 0.278 | 0.293 | Calpain 2 inhibitor | 0.293 0.119 DBMET02739 | DBMET02739 | |
| 0.136 | 0.294 | 0.192 | 5 Hydroxytryptamine 3E antagonist | 0.192 0.076 DBMET02739 0.182 0.1 DBMET02741 | DBMET02739 | |
| 0.034 | 0.195 | 0.078 | Antiadrenergic | 0.078 0.073 DBMET02740 | DBMET02740 | |
| 0.005 | 0.168 | 0.017 | Histamine H4 receptor agonist | 0.017 0.014 DBMET02741 | DBMET02741 | |
| 0.081 | 0.245 | 0.154 | GABA C receptor rho-2 antagonist | 0.154 0.069 DBMET02739 | DBMET02739 | |
| 0.032 | 0.201 | 0.107 | Protein kinase A inhibitor | 0.107 0.041 DBMET02741 | DBMET02741 | |
| 0.032 | 0.202 | 0.075 | Adrenaline antagonist | 0.075 0.072 DBMET02740 | DBMET02740 | |
| 0.025 | 0.203 | 0.086 | Histone deacetylase SIRT2 inhibitor | 0.086 0.04 DBMET02741 | DBMET02741 | |
| 0.012 | 0.189 | 0.034 | Melanocortin 1 antagonist | 0.034 0.03 DBMET02741 | DBMET02741 | |
| 0.058 | 0.237 | 0.132 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.132 0.092 DBMET02741 | DBMET02741 | |
| 0.095 | 0.275 | 0.137 | Phospholipase C inhibitor | 0.137 0.136 DBMET02741 | DBMET02741 | |
| 0.057 | 0.24 | 0.126 | Cathepsin H inhibitor | 0.114 0.083 DBMET02739 0.126 0.068 DBMET02741 | DBMET02741 | |
| 0.057 | 0.242 | 0.088 | Glutamate release inhibitor | 0.084 0.077 DBMET02739 0.088 0.066 DBMET02741 | DBMET02741 | |
| 0.026 | 0.211 | 0.082 | DNA gyrase inhibitor | 0.082 0.026 DBMET02739 | DBMET02739 | |
| 0.006 | 0.199 | 0.033 | Kinesin-like protein 1 inhibitor | 0.033 0.031 DBMET02741 | DBMET02741 | |
| 0.006 | 0.199 | 0.033 | Kinesin antagonist | 0.033 0.031 DBMET02741 | DBMET02741 | |
| 0.042 | 0.236 | 0.072 | Vanilloid 4 agonist | 0.072 0.059 DBMET02739 | DBMET02739 | |
| 0.03 | 0.23 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.034 DBMET02739 0.074 0.049 DBMET02741 | DBMET02739 | |
| 0.071 | 0.272 | 0.216 | Interleukin agonist | 0.216 0.106 DBMET02741 | DBMET02741 | |
| 0.041 | 0.255 | 0.138 | GABA C receptor antagonist | 0.138 0.037 DBMET02741 | DBMET02741 | |
| 0.042 | 0.257 | 0.132 | GABA C receptor rho-1 antagonist | 0.097 0.067 DBMET02739 0.132 0.031 DBMET02741 | DBMET02741 | |
| 0.069 | 0.291 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.101 DBMET02739 0.117 0.105 DBMET02740 | DBMET02739 | |
| 0.034 | 0.269 | 0.073 | Neuropeptide Y antagonist | 0.073 0.071 DBMET02739 | DBMET02739 | |
| 0.018 | 0.256 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | 0.073 0.058 DBMET02741 | DBMET02741 | |
| 0.014 | 0.263 | 0.065 | Cyclin A1 inhibitor | 0.065 0.03 DBMET02741 | DBMET02741 | |
| 0.024 | 0.281 | 0.077 | GABA aminotransferase inhibitor | 0.077 0.051 DBMET02741 | DBMET02741 | |
| 0.09 | 0.35 | 0.17 | DNA synthesis inhibitor | 0.17 0.168 DBMET02740 | DBMET02740 | |
| 0.014 | 0.276 | 0.052 | Histamine agonist | 0.052 0.037 DBMET02739 0.052 0.037 DBMET02741 | DBMET02741 | |
| 0.082 | 0.37 | 0.194 | Transcription factor STAT3 inhibitor | 0.194 0.142 DBMET02741 | DBMET02741 | |
| 0.029 | 0.321 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.058 0.054 DBMET02739 0.063 0.04 DBMET02741 | DBMET02741 | |
| 0.015 | 0.308 | 0.052 | GABA B receptor antagonist | 0.052 0.018 DBMET02741 | DBMET02741 | |
| 0.009 | 0.334 | 0.03 | Dipeptidyl peptidase II inhibitor | 0.03 0.027 DBMET02741 | DBMET02741 | |
| 0.026 | 0.36 | 0.111 | GABA C receptor agonist | 0.111 0.056 DBMET02741 | DBMET02741 | |
| 0.083 | 0.44 | 0.217 | Antibacterial | 0.217 0.21 DBMET02741 | DBMET02741 | |
| 0.014 | 0.385 | 0.087 | Inducible nitric-oxide synthase inhibitor | 0.087 0.052 DBMET02741 | DBMET02741 | |
| 0.054 | 0.486 | 0.206 | Transcription factor STAT inhibitor | 0.206 0.13 DBMET02741 | DBMET02741 | |
| 0.016 | 0.536 | 0.092 | 5 Hydroxytryptamine 3A agonist | 0.092 0.086 DBMET02741 | DBMET02741 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |